Peter Sunderland
Psychiatric/Mental Health · Canby, ORNPI 1467881813
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 37.1% of the total. Reporting peaked in 2022 at $753 and has fallen 71.2% since, to $217 in 2025. Among psychiatric/mental health clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$787
- Ironshore Pharmaceuticals Inc.$409
- Otsuka America Pharmaceutical, Inc.$389
- Corium, LLC$167
- AbbVie$93
- Takeda Pharmaceuticals U.S.A., Inc.$69
- plus $205 from 8 others
What the payments were for
- Food & beverage$2,112100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 66 | $787 |
| Ironshore Pharmaceuticals Inc. | 28 | $409 |
| Otsuka America Pharmaceutical, Inc. | 20 | $389 |
| Corium, LLC | 9 | $167 |
| AbbVie | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Alkermes, Inc. | 3 | $51 |
| Tempus AI, Inc | 1 | $28 |
| Lundbeck LLC | 1 | $25 |
| Noven Therapeutics, LLC | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $15 |
How this compares
$2,119 in reported general payments places this provider in the 90th percentile of 540 psychiatric/mental health providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 12 | $96 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Canby
- Amber HobergHillsboro$1.9M
- Tina Matthews-HayesPortland$787K
- Carmen KosicekHillsboro$539K
- Johnni CanslerPortland$529K
- Jill CarterPortland$416K
- William BettsEugene$41K
- Michelle VoegelsPortland$29K
- Rance SmithKlamath Falls$15K
- Jennifer BehnkeMcMinnville$14K
- Susan EllisRoseburg$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.